Rare Autism-Associated Variants Implicate Syntaxin 1 (STX1 R26Q) Phosphorylation and the Dopamine Transporter (hDAT R51W) in Dopamine Neurotransmission and Behaviors

EBioMedicine

Volumn 2, Issue 2, 2015, Pages 135-146

  Cartier, Etienne ^a   Hamilton, Peter J ^a   Belovich, Andrea N ^a   Shekar, Aparna ^a   Campbell, Nicholas G ^a   Saunders, Christine ^a   Andreassen, Thorvald F ^b   Gether, Ulrik ^b   Veenstra Vanderweele, Jeremy ^c   Sutcliffe, James S ^a   Ulery Reynolds, Paula G ^d   Erreger, Kevin ^a   Matthies, Heinrich J G ^a   Galli, Aurelio ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autism spectrum disorder; Casein kinase 2; Dopamine; Drosophila; Syntaxin 1; Transporter

Indexed keywords

DOPAMINE TRANSPORTER; SYNTAXIN 1;

AMPEROMETRY; ANIMAL TISSUE; ARTICLE; AUTISM; BEHAVIOR; BIOTINYLATION; DOPAMINERGIC TRANSMISSION; DROSOPHILA; GENE EXPRESSION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HIGH SPEED CHRONOAMPEROMETRY; HOMEOSTASIS; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 84929402811     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.01.007     Document Type: Article

References (56)

1. Rowberry J., Macari S., Chen G., et al. Screening for autism spectrum disorders in 12-month-old high-risk siblings by parental report. J. Autism Dev. Disord. 2015, 45(1):221-229.
2. Wolff J.J., Botteron K.N., Dager S.R., et al. Longitudinal patterns of repetitive behavior in toddlers with autism. J. Child Psychol. Psychiatry 2014, 55(8):945-953.
3. Langen M., Bos D., Noordermeer S.D., Nederveen H., van Engeland H., Durston S. Changes in the development of striatum are involved in repetitive behavior in autism. Biol. Psychiatry 2014, 76(5):405-411.
4. Langen M., Durston S., Staal W.G., Palmen S.J., van Engeland H. Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol. Psychiatry 2007, 62(3):262-266.
5. Langen M., Schnack H.G., Nederveen H., et al. Changes in the developmental trajectories of striatum in autism. Biol. Psychiatry 2009, 66(4):327-333.
6. Hollander E., Anagnostou E., Chaplin W., et al. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol. Psychiatry 2005, 58(3):226-232.
7. Dichter G.S., Richey J.A., Rittenberg A.M., Sabatino A., Bodfish J.W. Reward circuitry function in autism during face anticipation and outcomes. J. Autism Dev. Disord. 2012, 42(2):147-160.
8. Damiano C.R., Aloi J., Treadway M., Bodfish J.W., Dichter G.S. Adults with autism spectrum disorders exhibit decreased sensitivity to reward parameters when making effort-based decisions. J. Neurodev. Disord. 2012, 4(1):13.
9. Lin A., Rangel A., Adolphs R. Impaired learning of social compared to monetary rewards in autism. Front. Neurosci. 2012, 6:143.
10. Kohls G., Perino M.T., Taylor J.M., et al. The nucleus accumbens is involved in both the pursuit of social reward and the avoidance of social punishment. Neuropsychologia 2013, 51(11):2062-2069.
11. Kohls G., Thonessen H., Bartley G.K., et al. Differentiating neural reward responsiveness in autism versus ADHD. Dev. Cogn. Neurosci. 2014, 10C:104-116.
12. Zald D.H., Boileau I., El-Dearedy W., et al. Dopamine transmission in the human striatum during monetary reward tasks. J. Neurosci. 2004, 24(17):4105-4112.
13. Howe M.W., Tierney P.L., Sandberg S.G., Phillips P.E., Graybiel A.M. Prolonged dopamine signalling in striatum signals proximity and value of distant rewards. Nature 2013, 500(7464):575-579.
14. Howe M.W., Atallah H.E., McCool A., Gibson D.J., Graybiel A.M. Habit learning is associated with major shifts in frequencies of oscillatory activity and synchronized spike firing in striatum. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(40):16801-16806.
15. Fasano A., Petrovic I. Insights into pathophysiology of punding reveal possible treatment strategies. Mol. Psychiatry 2010, 15(6):560-573.
16. Kristensen A.S., Andersen J., Jorgensen T.N., et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol. Rev. 2011, 63(3):585-640.
17. Binda F., Dipace C., Bowton E., et al. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 2008, 74(4):1101-1108.
18. Quick M.W. The role of SNARE proteins in trafficking and function of neurotransmitter transporters. Handb. Exp. Pharmacol. 2006, 175:181-196.
19. Quick M.W. Regulating the conducting states of a mammalian serotonin transporter. Neuron 2003, 40(3):537-549.
20. Quick M.W. Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons. Int. J. Dev. Neurosci. 2002, 20(3-5):219-224.
21. Dipace C., Sung U., Binda F., Blakely R.D., Galli A. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol. Pharmacol. 2007, 71(1):230-239.
22. Nakamura K., Anitha A., Yamada K., et al. Genetic and expression analyses reveal elevated expression of syntaxin 1A (STX1A) in high functioning autism. Int. J. Neuropsychopharmacol. 2008, 11(8):1073-1084.
23. Nakamura K., Iwata Y., Anitha A., et al. Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(2):454-458.
24. Durdiakova J., Warrier V., Banerjee-Basu S., Baron-Cohen S., Chakrabarti B. STX1A and Asperger syndrome: a replication study. Mol. Autism 2014, 5(1):14.
25. Hamilton P.J., Campbell N.G., Sharma S., et al. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol. Psychiatry 2013, 18(12):1315-1323.
26. Bowton E., Saunders C., Reddy I.A., et al. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Transl. Psychiatry 2014, 4:e464.
27. Hettinger J.A., Liu X., Hudson M.L., et al. DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families. Behav. Brain Funct. 2012, 8:19.
28. Qian Y., Chen M., Forssberg H., Diaz Heijtz R. Genetic variation in dopamine-related gene expression influences motor skill learning in mice. Genes Brain Behav. 2013, 12(6):604-614.
29. Reiersen A.M., Todorov A.A. Association between DRD4 genotype and autistic symptoms in DSM-IV ADHD. J. Can. Acad. Child Adolesc. Psychiatry 2011, 20(1):15-21.
30. Yoo H.J., Cho I.H., Park M., Yang S.Y., Kim S.A. Association of the catechol-o-methyltransferase gene polymorphisms with Korean autism spectrum disorders. J. Korean Med. Sci. 2013, 28(9):1403-1406.
31. Nguyen M., Roth A., Kyzar E.J., et al. Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD). Neurochem. Int. 2014, 66:15-26.
32. Leviel V. Dopamine release mediated by the dopamine transporter, facts and consequences. J. Neurochem. 2011, 118(4):475-489.
33. Neale B.M., Kou Y., Liu L., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485(7397):242-245.
34. Lim E.T., Raychaudhuri S., Sanders S.J., et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 2013, 77(2):235-242.
35. Liu L., Sabo A., Neale B.M., et al. Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls. PLoS Genet. 2013, 9(4):e1003443.
36. De Rubeis S., He X., Goldberg A.P., et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515(7526):209-215.
37. Iossifov I., O'Roak B.J., Sanders S.J., et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014, 515(7526):216-221.
38. Bowton E., Saunders C., Erreger K., et al. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J. Neurosci. 2010, 30(17):6048-6057.
39. Castillo M.A., Ghose S., Tamminga C.A., Ulery-Reynolds P.G. Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biol. Psychiatry 2010, 67(3):208-216.
40. Kume K., Kume S., Park S.K., Hirsh J., Jackson F.R. Dopamine is a regulator of arousal in the fruit fly. J. Neurosci. 2005, 25(32):7377-7384.
41. Bose A., Kahali B., Zhang S., et al. Drosophila CK2 regulates lateral-inhibition during eye and bristle development. Mech. Dev. 2006, 123(9):649-664.
42. Lin J.M., Kilman V.L., Keegan K., et al. A role for casein kinase 2alpha in the Drosophila circadian clock. Nature 2002, 420(6917):816-820.
43. Rasmussen T., Skjoth I.H., Jensen H.H., Niefind K., Boldyreff B., Issinger O.G. Biochemical characterization of the recombinant human Drosophila homologues Timekeeper and Andante involved in the Drosophila circadian oscillator. Mol. Cell. Biochem. 2005, 274(1-2):151-161.
44. Hirling H., Scheller R.H. Phosphorylation of synaptic vesicle proteins: modulation of the alpha SNAP interaction with the core complex. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(21):11945-11949.
45. Foletti D.L., Lin R., Finley M.A., Scheller R.H. Phosphorylated syntaxin 1 is localized to discrete domains along a subset of axons. J. Neurosci. 2000, 20(12):4535-4544.
46. Khelashvili G., Galli A., Weinstein H. Phosphatidylinositol 4,5-biphosphate (PIP(2)) lipids regulate the phosphorylation of syntaxin N-terminus by modulating both its position and local structure. Biochemistry 2012, 51(39):7685-7698.
47. Dubois T., Kerai P., Learmonth M., Cronshaw A., Aitken A. Identification of syntaxin-1A sites of phosphorylation by casein kinase I and casein kinase II. Eur. J. Biochem. 2002, 269(3):909-914.
48. Matthies H.J., Han Q., Shields A., et al. Subcellular localization of the antidepressant-sensitive norepinephrine transporter. BMC Neurosci. 2009, 10:65.
49. Pizzo A.B., Karam C.S., Zhang Y., et al. The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. Mol. Psychiatry 2013, 18(7):824-833.
50. Hamilton P.J., Belovich A.N., Khelashvili G., et al. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Nat. Chem. Biol. 2014, 10(7):582-589.
51. Cousins D.A., Butts K., Young A.H. The role of dopamine in bipolar disorder. Bipolar Disord. 2009, 11(8):787-806.
52. Seeman P., Niznik H.B., Guan H.C. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride. Arch. Gen. Psychiatry 1990, 47(12):1170-1172.
53. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M., Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch. Neurol. 2007, 64(11):1575-1579.
54. Aksenova M.V., Burbaeva G.S., Kandror K.V., Kapkov D.V., Stepanov A.S. The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients. FEBS Lett. 1991, 279(1):55-57.
55. Sanders S.J., Ercan-Sencicek A.G., Hus V., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70(5):863-885.
56. Cook E.H., Lindgren V., Leventhal B.L., et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 1997, 60(4):928-934.